Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance
{{output}}
In recent years, therapy with immune modulating antibodies, termed immune checkpoint blockade (ICB), has revolutionized the treatment of advanced metastatic melanoma, yielding long-lasting clinical responses in a subgroup of patients. But despite this remarkab... ...
